JP2016135774A - Composition - Google Patents
Composition Download PDFInfo
- Publication number
- JP2016135774A JP2016135774A JP2016004262A JP2016004262A JP2016135774A JP 2016135774 A JP2016135774 A JP 2016135774A JP 2016004262 A JP2016004262 A JP 2016004262A JP 2016004262 A JP2016004262 A JP 2016004262A JP 2016135774 A JP2016135774 A JP 2016135774A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- olive
- mass
- composition
- olea europaea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 240000007817 Olea europaea Species 0.000 claims abstract description 72
- 239000000284 extract Substances 0.000 claims abstract description 71
- -1 phenylpropanoid glycoside Chemical class 0.000 claims abstract description 15
- YCIMNLLNPGFGHC-UHFFFAOYSA-N o-dihydroxy-benzene Natural products OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229930015704 phenylpropanoid Natural products 0.000 claims abstract description 7
- 229930182470 glycoside Natural products 0.000 claims abstract description 5
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 claims description 42
- 235000003248 hydroxytyrosol Nutrition 0.000 claims description 21
- 229940095066 hydroxytyrosol Drugs 0.000 claims description 21
- 235000013399 edible fruits Nutrition 0.000 claims description 20
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 16
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 13
- KDSWDGKIENPKLB-QJDQKFITSA-N verbascoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)CCC=2C=C(O)C(O)=CC=2)[C@@H](CO)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O KDSWDGKIENPKLB-QJDQKFITSA-N 0.000 claims description 13
- QFRYQWYZSQDFOS-UHFFFAOYSA-N verbascoside Natural products CC1OC(COC2C(O)C(COC3OC(C(O)C(O)C3O)C(=O)O)OC(Oc4cc(O)cc5OC(=CC(=O)c45)c6ccc(O)c(O)c6)C2O)C(O)C(O)C1O QFRYQWYZSQDFOS-UHFFFAOYSA-N 0.000 claims description 13
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 8
- 229940074360 caffeic acid Drugs 0.000 claims description 8
- 235000004883 caffeic acid Nutrition 0.000 claims description 8
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 8
- FSBUXLDOLNLABB-ISAKITKMSA-N echinacoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)\C=C\C=2C=C(O)C(O)=CC=2)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O FSBUXLDOLNLABB-ISAKITKMSA-N 0.000 claims description 7
- NJYVDFDTLLZVMG-UHFFFAOYSA-N echinacoside Natural products CC1OC(OC2C(O)C(OCCc3ccc(O)c(O)c3)OC(COC4OC(CO)C(O)C(O)C4O)C2OC(=O)C=Cc5cc(O)cc(O)c5)C(O)C(O)C1O NJYVDFDTLLZVMG-UHFFFAOYSA-N 0.000 claims description 7
- YSCJAYPKBYRXEZ-HZPINHDXSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-hydroxy-4-[(2s,3r,4s, Chemical compound O([C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CCC(C[C@H]14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C(O)=O)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O YSCJAYPKBYRXEZ-HZPINHDXSA-N 0.000 claims 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 abstract description 20
- 235000002725 Olea europaea Nutrition 0.000 abstract description 8
- 235000015203 fruit juice Nutrition 0.000 abstract description 6
- 239000000843 powder Substances 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 239000007902 hard capsule Substances 0.000 abstract description 3
- 235000015110 jellies Nutrition 0.000 abstract description 3
- 239000007901 soft capsule Substances 0.000 abstract description 3
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 150000008442 polyphenolic compounds Chemical class 0.000 description 10
- 235000013824 polyphenols Nutrition 0.000 description 10
- 239000003963 antioxidant agent Substances 0.000 description 9
- 235000006708 antioxidants Nutrition 0.000 description 9
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 8
- 235000004330 tyrosol Nutrition 0.000 description 8
- 235000013305 food Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000207836 Olea <angiosperm> Species 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical group C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical group C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- RFWGABANNQMHMZ-UHFFFAOYSA-N 8-acetoxy-7-acetyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline Natural products CC=C1C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O RFWGABANNQMHMZ-UHFFFAOYSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- HKVGJQVJNQRJPO-UHFFFAOYSA-N Demethyloleuropein Natural products O1C=C(C(O)=O)C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(=CC)C1OC1OC(CO)C(O)C(O)C1O HKVGJQVJNQRJPO-UHFFFAOYSA-N 0.000 description 1
- 108010061711 Gliadin Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- RFWGABANNQMHMZ-HYYSZPHDSA-N Oleuropein Chemical compound O([C@@H]1OC=C([C@H](C1=CC)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-HYYSZPHDSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000008531 oleocanthal Nutrition 0.000 description 1
- VPOVFCBNUOUZGG-VAKDEWRISA-N oleocanthal Chemical compound C\C=C(\C=O)[C@@H](CC=O)CC(=O)OCCC1=CC=C(O)C=C1 VPOVFCBNUOUZGG-VAKDEWRISA-N 0.000 description 1
- 235000011576 oleuropein Nutrition 0.000 description 1
- RFWGABANNQMHMZ-CARRXEGNSA-N oleuropein Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C(=CC)[C@H]1CC(=O)OCCc3ccc(O)c(O)c3 RFWGABANNQMHMZ-CARRXEGNSA-N 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本発明は、オリーブ抽出物の抗酸化作用を向上した組成物に関する。 The present invention relates to a composition having an improved antioxidant effect of olive extract.
抗酸化作用を有するポリフェノールは身体の中の酸化ストレスを抑制するため、身体によいとされている。オリーブには、抗酸化ポリフェノールが多く含まれているため、古くから、食用・薬用として利用されてきた。また、オリーブに含まれる抗酸化ポリフェノールのうち、ヒドロキシチロソールは、血管のLDL酸化抑制効果や動脈硬化の予防作用を裏付ける報告がなされている(非特許文献1)。したがって、有効量以上のヒドロキシチロソールを継続的に摂取すれば、血管のLDL酸化抑制効果や動脈硬化症の予防や改善が期待できる。
近年では、オリーブ由来の抗酸化ポリフェノールを効率的に摂取できるよう、オリーブの各部分をエキス化した原料が市販されている。しかし、ポリフェノールは抗酸化作用をもつが故、自身は容易に酸化され、不安定である。従来、グリアジンで被覆したメロンSOD活性抽出物に、アスタキサンチンやレスベラトロールが退色したり分解したりするのを抑える方法(特許文献1)や、食塩含有食品加工残液及び残渣に由来する食塩をある程度残存させることにより、ポリフェノール還元態を保持して、ポリフェノールの抗酸化作用を維持する方法(特許文献2)が報告されている。しかし、これらの方法では、コストや風味の点で課題が残る。
Polyphenols having an antioxidant action are said to be good for the body because they suppress oxidative stress in the body. Olives are rich in antioxidant polyphenols and have been used for food and medicine since ancient times. In addition, among the antioxidant polyphenols contained in olives, hydroxytyrosol has been reported to support the effect of inhibiting vascular LDL oxidation and the effect of preventing arteriosclerosis (Non-patent Document 1). Therefore, if an effective amount or more of hydroxytyrosol is continuously ingested, the LDL oxidation inhibitory effect of blood vessels and the prevention and improvement of arteriosclerosis can be expected.
In recent years, raw materials obtained by extracting each part of olive are commercially available so that an antioxidant polyphenol derived from olive can be efficiently ingested. However, because polyphenols have an antioxidant action, they are easily oxidized and unstable. Conventionally, a method for suppressing fading or decomposition of astaxanthin and resveratrol on melon SOD active extract coated with gliadin (Patent Document 1), salt-containing food processing residual liquid and salt derived from residue A method (Patent Document 2) that maintains the polyphenol reduced state and maintains the antioxidant action of polyphenol by allowing it to remain to some extent has been reported. However, these methods still have problems in terms of cost and flavor.
本発明は、オリーブ抽出物の抗酸化作用を維持できる組成物を提供することを課題とする。 An object of the present invention is to provide a composition capable of maintaining the antioxidant action of an olive extract.
本発明者らは、上記課題を解決すべく鋭意検討を行った結果、フェニルプロパノイド配糖体、カテコール化合物、及びオリーブ抽出物を含有し、これらを特定比率で含む組成物、あるいは、オリーブ抽出物としてオリーブ果汁抽出物とオリーブ果肉抽出物を混合した組成物は、意外にもオリーブ抽出物の抗酸化作用を維持できることを見出し、本発明を完成した。 As a result of intensive studies to solve the above problems, the inventors of the present invention contain a phenylpropanoid glycoside, a catechol compound, and an olive extract, and a composition containing these in a specific ratio, or an olive extract Surprisingly, it was found that a composition obtained by mixing an olive juice extract and an olive pulp extract as a product can maintain the antioxidant action of the olive extract, and the present invention has been completed.
すなわち、本発明は、
(1)(a)フェニルプロパノイド配糖体、(b)カテコール化合物、及び(c)オリーブ抽出物を含み、カテコール化合物の含量がフェニルプロパノイド配糖体1質量部に対して0.5質量部以上であることを特徴とする組成物、
(2)(a)ベルバスコシド及び/又はエキナコシド、(b)ヒドロキシチロソール及び/又はカフェイン酸、及び(c)オリーブ抽出物を含み、(b)の含有量が、(a)1質量部に対して0.5質量部以上である組成物、
(3)(c)のオリーブ抽出物が、オリーブ果実抽出物である、(1)又は(2)に記載の組成物、
(4)オリーブ果実抽出物が、オリーブ果汁抽出物とオリーブ果肉抽出物を含む、(3)に記載の組成物、
(5)オリーブ果肉抽出物及びオリーブ果汁抽出物を含有する組成物、
(6)ヒドロキシチロソールを、成人一人当たり1日量として5mg以上摂取されるように配合されていることを特徴とする(2)に記載の組成物、
である。
That is, the present invention
(1) (a) a phenylpropanoid glycoside, (b) a catechol compound, and (c) an olive extract, wherein the content of the catechol compound is 0.5 mass relative to 1 part by mass of the phenylpropanoid glycoside Part or more of a composition,
(2) (a) Verbascoside and / or echinacoside, (b) hydroxytyrosol and / or caffeic acid, and (c) olive extract, the content of (b) is (a) 1 part by mass A composition that is 0.5 parts by weight or more,
(3) The composition according to (1) or (2), wherein the olive extract of (c) is an olive fruit extract,
(4) The composition according to (3), wherein the olive fruit extract comprises an olive juice extract and an olive pulp extract,
(5) a composition comprising an olive pulp extract and an olive juice extract;
(6) The composition according to (2), wherein hydroxytyrosol is formulated so as to be ingested in an amount of 5 mg or more per adult per day,
It is.
本発明により、オリーブ抽出物の経時的な抗酸化作用の低下を抑制した組成物を提供することが可能となった。 According to the present invention, it is possible to provide a composition that suppresses a decrease in the antioxidant effect of the olive extract over time.
本発明のフェニルプロパノイド配糖体とは、ベルバスコシド、エキナコシド等が挙げられる。また、本発明のカテコール化合物とは、ヒドロキシチロソール、カフェイン酸等が挙げられる。 Examples of the phenylpropanoid glycoside of the present invention include vervascoside and echinacosid. Examples of the catechol compound of the present invention include hydroxytyrosol and caffeic acid.
本発明のオリーブ抽出物とは、天然のオリーブ(Olea europaea)から分離される抽出物であり、分離箇所としては果実(果肉、果汁、種子)、葉等が挙げられる。本発明において好ましい部位は、果実である。
本発明のオリーブ果実抽出物としては、市販のオリーブ果実抽出物を適宜選択すればよい。例えば、Olivex HT6(果汁抽出物、抽出方法:エタノール抽出(オリーブ果実を圧搾して得られたオリーブ果汁を酸処理後、エタノールにて濾過・精製し粉末化したもの)、総ポリフェノール量:30質量%以上含有、ヒドロキシチロソール:6質量%以上含有、チロソール:1質量%以上含有)、Oleaselect(果肉抽出物、抽出方法:水とエタノールの混合溶媒抽出(オリーブ果実より水とエタノールの混合溶媒にて抽出し粉末化したもの)、総ポリフェノール量:30質量%以上含有、ベルバスコシド量:5質量%以上含有、ヒドロキシチロソール:1.5質量%以上含有)、OPEXTAN(果肉抽出物、抽出方法:水とエタノールの混合溶媒抽出(オリーブ果実より水とエタノールの混合溶媒にて抽出し粉末化したもの)、総フェノール量:10質量%以上含有、ベルバスコシド量:2.0〜3.5質量%含有、ヒドロキシチロソール及びその誘導体:4.5質量%以上含有)、Hytolive(果実抽出物、ヒドロキシチロソール量:8質量%以上含有)、Polyphen−Oil(果実抽出物、総ポリフェノール量:6.5質量%含有、ヒドロキシチロソールまたはチロソール量:1.73質量%含有、ベルバスコシドまたはオレウロペイン量:0.5質量%含有)を利用することができる。
The olive extract of the present invention is an extract that is separated from natural olive (Olea europaea), and examples of the separation location include fruits (fruit pulp, fruit juice, seeds), leaves and the like. A preferred site in the present invention is a fruit.
What is necessary is just to select a commercially available olive fruit extract suitably as an olive fruit extract of this invention. For example, Olivex HT6 (fruit juice extract, extraction method: ethanol extraction (olive fruit juice obtained by squeezing olive fruit, acid-treated, filtered and purified with ethanol), total polyphenol content: 30 mass % Or more, hydroxytyrosol: 6% by weight or more, tyrosol: 1% by weight or more), Oleaselect (pulp extract, extraction method: mixed solvent extraction of water and ethanol (from olive fruit to a mixed solvent of water and ethanol) Extracted and powdered), total polyphenol content: 30% by mass or more, verbascoside content: 5% by mass or more, hydroxytyrosol: 1.5% by mass or more), OPEXTAN (fruit extract, extraction method: Extraction of water and ethanol in a mixed solvent (extracted from olive fruit with a mixed solvent of water and ethanol and powdered) 1), total phenol content: 10% by mass or more, Verbascoside content: 2.0-3.5% by mass content, hydroxytyrosol and its derivatives: 4.5% by mass or more), Hytolive (fruit extract, hydroxy Tyrosol content: 8% by mass or more), Polyphen-Oil (fruit extract, total polyphenol content: 6.5% by mass content, hydroxytyrosol or tyrosol content: 1.73% by mass content, verbascoside or oleuropein content: 0 .5 mass% content) can be used.
また、本発明のオリーブ果実抽出物は、ヒドロキシチロソールを豊富に含むオリーブ果汁抽出物と、ベルバスコシドを豊富に含むオリーブ果肉抽出物とを組み合わせて配合するのがより好ましい。また、オリーブ果実抽出物の配合に際し、オリーブ果汁抽出物とオリーブ果肉抽出物を配合する場合は、本発明の効果の点からオリーブ果汁抽出物1質量部に対してオリーブ果肉抽出物を10質量部を上限に配合することが好ましく、より好ましくは0.54質量部〜10質量部、さらに好ましくは0.75質量部〜10質量部である。 The olive fruit extract of the present invention is more preferably formulated by combining an olive juice extract rich in hydroxytyrosol and an olive pulp extract rich in verbascoside. In addition, when the olive fruit extract is blended with the olive fruit extract and the olive fruit extract, 10 parts by weight of the olive fruit extract is used with respect to 1 part by weight of the olive juice extract in view of the effect of the present invention. It is preferable to mix | blend to the upper limit, More preferably, it is 0.54 mass part-10 mass parts, More preferably, it is 0.75 mass part-10 mass parts.
本発明の組成物中のヒドロキシチロソール又はカフェイン酸の含有量は、本発明の効果の点からベルバスコシド又はエキナコシド1質量部に対して0.5質量部以上である。より好ましくは、0.51質量部〜1.46質量部が好ましく、より好ましくは、0.51質量部〜1.19質量部である。 The content of hydroxytyrosol or caffeic acid in the composition of the present invention is 0.5 parts by mass or more with respect to 1 part by mass of verbascoside or echinacoside from the viewpoint of the effect of the present invention. More preferably, it is 0.51 mass part-1.46 mass part, More preferably, it is 0.51 mass part-1.19 mass part.
また、本発明の組成物には、さらにモノフェノール化合物が含有されていることが好ましい。モノフェノール化合物としてはチロソール、チロシン、オレオカンタール等が挙げられるが、好ましくはチロソールである。モノフェノール化合物の配合量としては、本発明の組成物中、0.9質量%以上が好ましい。 Moreover, it is preferable that the composition of this invention contains the monophenol compound further. Examples of the monophenol compound include tyrosol, tyrosine, oleocanthal and the like, and tyrosol is preferable. As a compounding quantity of a monophenol compound, 0.9 mass% or more is preferable in the composition of this invention.
また、上記ベルバスコシド、ヒドロキシチロソール及びチロソールは、オリーブ抽出物に含まれる成分であるため、上記割合となるよう、果肉、果汁等の各部位から抽出されるオリーブ抽出物を適宜の割合で配合すればよい。また、オリーブ抽出物とは別に、ベルバスコシド、エキナコシド、ヒドロキシチロソール、カフェイン酸又はチロソール、及びこれら化合物を含む天然由来の抽出物を上記割合となるよう添加してもよい。 In addition, since the above-mentioned verbascoside, hydroxytyrosol and tyrosol are components contained in the olive extract, the olive extract extracted from each part such as pulp and fruit juice should be blended at an appropriate ratio so as to have the above ratio. That's fine. Apart from the olive extract, verbascoside, echinacoside, hydroxytyrosol, caffeic acid or tyrosol, and naturally occurring extracts containing these compounds may be added in the above proportions.
また、本発明の組成物中のヒドロキシチロソールは、成人一人当たり、1日に5mg以上摂取されるよう配合されていると、例えば血管のLDL酸化抑制効果などの抗酸化効果が期待でき、好ましい。より好ましくは成人一人当たり、1日に6mg以上の配合である。 In addition, when hydroxytyrosol in the composition of the present invention is formulated so that 5 mg or more per day is taken per adult, an antioxidative effect such as an inhibitory effect on LDL oxidation of blood vessels can be expected. . More preferably, it is 6 mg or more per day per adult.
本発明の組成物の形態としては、飲料、粉末、粉末飲料、錠剤、サプリメント、ゼリー、ハードカプセルまたはソフトカプセル、化粧品などを挙げることができるが、好ましくは経口摂取される飲料、粉末、粉末飲料、錠剤、ゼリー、ハードカプセルまたはソフトカプセルである。 Examples of the form of the composition of the present invention include beverages, powders, powdered beverages, tablets, supplements, jelly, hard capsules or soft capsules, cosmetics, etc., preferably beverages, powders, powdered beverages, tablets to be taken orally. , Jelly, hard capsule or soft capsule.
以下に、実施例、比較例及び試験例を挙げ、本発明を更に詳細に説明する。 なお、オリーブ果汁抽出物として市販のOlivex HT6を、オリーブ果肉抽出物として市販のOleaselectを使用した。また、各成分の含量は、HPLC法により測定した。 Hereinafter, the present invention will be described in more detail with reference to Examples, Comparative Examples and Test Examples. In addition, commercially available Olivex HT6 was used as the olive juice extract, and commercially available Oleaselect was used as the olive pulp extract. Moreover, the content of each component was measured by HPLC method.
比較例1
オリーブ果汁抽出物を使用した。
Comparative Example 1
Olive juice extract was used.
実施例1
比較例1のオリーブ果汁抽出物13質量部に対し、オリーブ果肉抽出物7質量部を添加し、混合した。
Example 1
7 parts by mass of olive pulp extract was added to and mixed with 13 parts by mass of olive juice extract of Comparative Example 1.
実施例2
比較例1のオリーブ果汁抽出物4質量部に対し、オリーブ果肉抽出物3質量部を添加し、混合した。
Example 2
3 parts by mass of olive pulp extract was added to and mixed with 4 parts by mass of olive juice extract of Comparative Example 1.
実施例3
比較例1のオリーブ果汁抽出物1質量部に対し、オリーブ果肉抽出物10質量部を添加し、混合した。
Example 3
To 1 part by mass of the olive juice extract of Comparative Example 1, 10 parts by mass of olive pulp extract was added and mixed.
実施例4
比較例1のオリーブ果汁抽出物20質量部に対し、エキナコシド1質量部を添加し,混合した。すなわち、組成物中ヒドロキシチロソールを5.7%、エキナコシドを4.8%含有する。
Example 4
1 part by mass of echinacoside was added to and mixed with 20 parts by mass of the olive juice extract of Comparative Example 1. That is, the composition contains 5.7% hydroxytyrosol and 4.8% echinacoside.
実施例5
オリーブ果肉抽出物50質量部に対し、カフェイン酸3質量部を添加し、混合した。すなわち、組成物中ヒドロキシチロソール及びカフェイン酸を合計として、10.4%、ベルバスコシドを10.4%含有する。
Example 5
3 parts by weight of caffeic acid was added to and mixed with 50 parts by weight of the olive pulp extract. That is, the composition contains 10.4% of hydroxytyrosol and caffeic acid in total and 10.4% of verbascoside.
以下表1に、比較例1及び実施例1〜3の組成物中に含まれるベルバスコシド、エキナコシド、ヒドロキシチロソール、カフェイン酸の含量(%)を、表2に実施例1〜3の処方を示す。 Table 1 below shows the contents (%) of verbascoside, echinacoside, hydroxytyrosol and caffeic acid contained in the compositions of Comparative Example 1 and Examples 1-3, and Table 2 shows the formulations of Examples 1-3. Show.
試験例:組成物の抗酸化能評価
(1)方法
比較例1及び実施例1〜5に示した組成物を一定量量りとり、ジメチルスルホキシド(国産化学製)に溶かしたものを試験に供した。抗酸化能評価はフリーラジカル評価装置(F.R.E.E.:DIACRON)を使用し、Biological Anti−oxidant potential test(BAP test kit:Diacron)にて行った。85℃6日保存後の抗酸化能変化率を表3に示す。
Test Example: Evaluation of Antioxidant Capacity of Composition (1) Method A certain amount of the composition shown in Comparative Example 1 and Examples 1 to 5 was weighed out and dissolved in dimethyl sulfoxide (manufactured by Kokusan Kagaku) and subjected to the test . Antioxidant ability evaluation was performed in a biological anti-oxidant potential test (BAP test kit: Diacron) using a free radical evaluation apparatus (FREE: DIACRON). Table 3 shows the rate of change in antioxidant capacity after storage at 85 ° C. for 6 days.
(2)結果
表3に示す通り、実施例1〜5の変化率は、比較例1よりも安定であった。オリーブ果肉又はベルバスコシドの含有量が増えるにつれ、抗酸化能変化率の低下が抑制され、実施例3の処方の比率においてもっとも効果が高いという結果であった。
本発明の組成物は、オリーブ抽出物の経時的な抗酸化力の低下を抑制できるものであることが分かった。なお、比較例1及び実施例1〜4のチロソールの含量は、いずれも1%であり、実施例5は0.9%であった。実施例に使用したオリーブ果肉抽出物中の各成分の含量をHPLC法により測定した結果、ベルバスコシド11%、ヒドロキシチロソール5%、チロソール1%であった。
(2) Results As shown in Table 3, the rate of change in Examples 1 to 5 was more stable than that in Comparative Example 1. As the content of olive pulp or verbascoside increased, the decrease in the antioxidant capacity change rate was suppressed, and the result was the most effective in the ratio of the formulation of Example 3.
It has been found that the composition of the present invention can suppress a decrease in the antioxidant power of the olive extract over time. The contents of tyrosol in Comparative Example 1 and Examples 1 to 4 were all 1%, and Example 5 was 0.9%. The content of each component in the olive pulp extract used in the examples was measured by HPLC, and as a result, it was 11% verbascoside, 5% hydroxytyrosol, and 1% tyrosol.
実施例6
比較例1のオリーブ果汁抽出物にオリーブ果肉抽出物を各成分が表4に示す含量になるように添加したものを調製した。また、その調製物を1日量110mgとしたときの各成分の量(mg)を表4に示す。
Example 6
An olive fruit juice extract of Comparative Example 1 was prepared by adding an olive pulp extract so that each component had a content shown in Table 4. In addition, Table 4 shows the amount (mg) of each component when the preparation is made to have a daily dose of 110 mg.
本発明により、経時的な抗酸化作用低下を抑制した、商品価値の高いオリーブ抽出物配合組成物を提供することが可能となった。医薬、食品、機能性表示食品、特定保健用食品、化粧品の分野に利用できる。 According to the present invention, it is possible to provide an olive extract blended composition having a high commercial value that suppresses a decrease in antioxidant effect over time. It can be used in the fields of medicine, food, functional labeling food, food for specified health use and cosmetics.
Claims (6)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015008478 | 2015-01-20 | ||
JP2015008478 | 2015-01-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2016135774A true JP2016135774A (en) | 2016-07-28 |
Family
ID=56512870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016004262A Pending JP2016135774A (en) | 2015-01-20 | 2016-01-13 | Composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2016135774A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019530465A (en) * | 2016-10-18 | 2019-10-24 | ブレスリン,ポール | Glucose drink containing exogenous flavor source and color |
-
2016
- 2016-01-13 JP JP2016004262A patent/JP2016135774A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019530465A (en) * | 2016-10-18 | 2019-10-24 | ブレスリン,ポール | Glucose drink containing exogenous flavor source and color |
JP6995850B2 (en) | 2016-10-18 | 2022-01-17 | ブレスリン,ポール | Glucose beverage containing extrinsic flavor sources and colors |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11564952B2 (en) | Water-soluble and water-insoluble propolis products with high antioxidant capacity and their production methods | |
JP2009161459A (en) | Endurance-improving agent | |
JP2009263257A (en) | Agent for preventing and/or improving fatty liver | |
JP6812102B2 (en) | Powdered green juice drink | |
JP2015017044A (en) | Agent for fat accumulation inhibition and/or fat accumulation amount reduction | |
JP2007045814A (en) | Cholesterol regulating agent | |
JP2016135774A (en) | Composition | |
JP2014208600A (en) | Composition comprising useful component in turmeric | |
JP2011244833A (en) | Food having action to lower human serum cholesterol level and preventive or treating agent for human hypercholesterolemia | |
JP2012131760A (en) | Fatty acid absorption inhibitor | |
JP6392455B2 (en) | Urinary symptom improving agent | |
JP5801515B1 (en) | Tomato-containing food and drink | |
JP7271017B2 (en) | Composition for suppressing elevation of blood cholesterol | |
JP7140865B2 (en) | water-soluble composition | |
JP7320243B2 (en) | Citral-containing composition | |
JP7504609B2 (en) | Composition containing lignan compounds dissolved in clove oil, and method for increasing solubility of sesamin | |
JP2012102059A (en) | Antidepressant | |
JP2018050566A (en) | Food composition containing ampelopsin and fish oil | |
JP2019176828A (en) | Oral composition | |
JP2014183849A (en) | Food having human serum cholesterol value reduction action, and preventive or therapeutic agent for human being hypercholesterolemia | |
Nuchanart et al. | The comparative study of the protective effect on human oxidative hemolysis of polyphenol extracts from tea seed oil and olive oil | |
JP2023089202A (en) | Blood cholesterol rise inhibitory composition | |
JP6024371B2 (en) | Herbal extract-containing liquid composition | |
JP2018050567A (en) | Food composition containing hydroxytyrosol and fish oil | |
AU2021240819A1 (en) | Quercetin enhancement formulation |